India to Malaysia: Gemcitabine Export Trade Route

The India to Malaysia Gemcitabine corridor is one of India's established pharmaceutical export routes, with 44 shipments documented worth a combined $1.4M USD. The route is dominated by VENUS REMEDIES LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's gemcitabine manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $31.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with gemcitabine's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 13.9%, placing it at rank #7 among India's top gemcitabine export destinations globally.

On the import side, key buyers of Indian gemcitabine in Malaysia include FRESENIUS KABI MALAYSIA SDN BHD, M.E.L.S.B, M E L S B and 6 others. FRESENIUS KABI MALAYSIA SDN BHD is the single largest importer with 20 shipments valued at $334.9K USD.

India's gemcitabine exports to Malaysia are driven primarily by a handful of large-scale manufacturers. VENUS REMEDIES LIMITED with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Malaysia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VENUS REMEDIES LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together account for 88% of total trade value on this route. The average shipment value of $31.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as citabol 1000 mg (gemcitabine powder for and citabol 1000 mg gemcitabine powder forsolution for infusion 1000 mg, suggesting that buyers in Malaysia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI MALAYSIA SDN BHD is the largest importer with 20 shipments worth $334.9K USD — representing 24% of all gemcitabine imports from India on this route. A total of 9 buyers are active on this corridor.